CAPPED BONUSZERTIFIKAT - MERCK & CO. Share Price

Certificat

DE000PC67M88

Market Closed - Börse Stuttgart 01:03:31 28/06/2024 pm IST
104.6 EUR -0.28% Intraday chart for CAPPED BONUSZERTIFIKAT - MERCK & CO.
Current month+3.25%
1 month+2.71%
Date Price Change
28/24/28 104.6 -0.28%
27/24/27 104.9 -0.19%
26/24/26 105.1 +0.13%
25/24/25 104.9 +0.28%
24/24/24 104.6 +0.02%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 01:03 pm IST

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC67M8
ISINDE000PC67M88
Date issued 25/03/2024
Strike 120 $
Maturity 20/06/2025 (355 Days)
Parity 1 : 1
Emission price 98.2
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 105.1
Lowest since issue 100
Spread 0.02
Spread %0.02%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
123.8 USD
Average target price
142.7 USD
Spread / Average Target
+15.25%
Consensus